rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

ClearPoint Neuro Inc.

CLPT · Nasdaq

Health CareMedical DevicesNot moving yet

CLPT stood above a rising 150-day average in 18 of the last 52 weekly readings, and has been out of that trend for the last 3 weeks. It is 31.1% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 3
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$4.9M
Officials’ trades on record
0
Institutions holding
127 (+15)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$3.0M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months8
Buyers · sellers0 · 4
WhoDidSharesTraded
Joseph BurnettCEO and Presidentsold20,000at $19.3829 Jun 2026filed 1 Jul 2026
Joseph BurnettCEO and Presidentsold60,000at $17.7917 Jun 2026filed 22 Jun 2026
Joseph BurnettCEO and Presidentsold1,843at $17.9417 Jun 2026filed 22 Jun 2026
Timothy T. RichardsDirectorsold5,415at $12.171 Jun 2026filed 2 Jun 2026
Matthew B. KleinDirectorsold16,000at $11.5921 May 2026filed 26 May 2026
Lynnette C. FallonDirectorsold5,091at $11.1420 May 2026filed 21 May 2026
Joseph BurnettCEO and Presidentsold19,951at $15.1725 Feb 2026filed 26 Feb 2026
Joseph BurnettCEO and Presidentsold2,943at $15.5726 Jan 2026filed 27 Jan 2026
Joseph BurnettCEO and Presidentsold20,000at $16.129 Jan 2026filed 13 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders127+15 on the quarter
New · exited27 · 11
Reported value$248.9M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20262,379,804$42.5M+297,054+14.3%
MAK CAPITAL ONE LLCadded · filed 14 Aug 20262,375,861$42.4M+474,372+24.9%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20261,232,807$22.0M-10,808−0.9%
STATE STREET CORPadded · filed 7 Aug 2026816,547$14.6M+136,728+20.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026749,932$13.4M+44,212+6.3%
Lane Generational LLCreduced · filed 13 Aug 2026444,831$7.9M-42,018−8.6%
UBS Group AGreduced · filed 13 Aug 2026428,632$7.6M-3,728−0.9%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026357,676$6.4M+125,702+54.2%
BROWN ADVISORY INCunchanged · filed 14 Aug 2026325,906$5.8M00.0%
COMPASS FINANCIAL MANAGEMENT LLCnew · filed 12 Aug 2026295,680$5.3M+295,680
31 Mar 2023 – 30 Jun 2026
5087124Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

R. John Fletcher Company insiderDirector · last 1 Oct 20260 · 0
Timothy T. Richards Company insiderDirector · last 1 Oct 20261 · 2
Joseph Burnett Company insiderCEO and President · last 2 Sep 20264 · 11
Danilo D'Alessandro Company insiderChief Financial Officer · last 30 Jun 20260 · 0
L. Jeremy Stigall Company insiderChief Business Officer · last 30 Jun 20260 · 0
B. Kristine Johnson Company insiderDirector · last 21 May 20260 · 0
Linda M. Liau Company insiderDirector · last 21 May 20260 · 0
Lynnette C. Fallon Company insiderDirector · last 21 May 20260 · 2
Matthew B. Klein Company insiderDirector · last 21 May 20260 · 1
Pascal E. R. Girin Company insiderDirector · last 19 May 20260 · 0
Mazin Sabra Company insiderChief Operating Officer · last 12 Mar 20260 · 0
Peter G. Piferi Company insiderChief Operating Officer · last 20 Aug 20210 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202561.4%
Operating profit marginFY 2025 · to 31 Dec 2025-65.4%
Free cash flow marginFY 2025 · to 31 Dec 2025-66.1%
Return on capital employedFY 2025 · to 31 Dec 2025-27.8%
Debt to equityFY 2025 · to 31 Dec 20251.75×
Research spendFY 2025 · to 31 Dec 202537.6%
Share count trendFY 2025 · to 6 Mar 20261.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$45.9M
Free cash flowFY 2025 · to 31 Dec 2025−$24.4M

Analyst forecasts

No analyst forecasts yet.